The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa : Novel Agents for Combination Therapy
Open accessAbstract
Whole-cell assays were implemented to search for efflux pump inhibitors (EPIs) of the three multidrug resistance efflux pumps (MexAB-OprM, MexCD-OprJ, MexEF-OprN) that contribute to fluoroquinolone resistance in clinical isolates of Pseudomonas aeruginosa . Secondary assays were developed to identify lead compounds with exquisite activities as inhibitors. A broad-spectrum EPI which is active against all three known Mex efflux pumps from P. aeruginosa and their close Escherichia coli efflux pump homolog (AcrAB-TolC) was discovered. When this compound, MC-207,110, was used, the intrinsic resistance of P. aeruginosa to fluoroquinolones was decreased significantly (eightfold for levofloxacin). Acquired resistance due to the overexpression of efflux pumps was also decreased (32- to 64-fold reduction in the MIC of levofloxacin). Similarly, 32- to 64-fold reductions in MICs in the presence of MC-207,110 were observed for strains with overexpressed efflux pumps and various target mutations that confer resistance to levofloxacin (e.g., gyrA and parC ). We also compared the frequencies of emergence of levofloxacin-resistant variants in the wild-type strain at four times the MIC of levofloxacin (1 μg/ml) when it was used either alone or in combination with EPI. In the case of levofloxacin alone, the frequency was ∼10 −7 CFU/ml. In contrast, with an EPI, the frequency was below the level of detection (<10 −11 ). In summary, we have demonstrated that inhibition of efflux pumps (i) decreased the level of intrinsic resistance significantly, (ii) reversed acquired resistance, and (iii) resulted in a decreased frequency of emergence of P. aeruginosa strains that are highly resistant to fluoroquinolones.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Molecular basis of bacterial outer membrane permeability
Nikaido, H., & Vaara, M. (1985) · Microbiological Reviews · doi:10.1128/mmbr.49.1.1-32.1985 · Cited by 2,447
Agents that increase the permeability of the outer membrane
Vaara, M. (1992) · Microbiological Reviews · doi:10.1128/mr.56.3.395-411.1992 · Cited by 1,879
Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,540
Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli
Yoshida, H., Bogaki, M., Nakamura, M., Yamanaka, L. M., & Nakamura, S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.8.1647 · Cited by 777
Poole, K., Krebes, K., McNally, C., & Neshat, S. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.22.7363-7372.1993 · Cited by 688
Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli
Yoshida, H., Bogaki, M., Nakamura, M., & Nakamura, S. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1271 · Cited by 570
Ko¨hler, T., Michéa‐Hamzehpour, M., Henze, U., Gotoh, N., Kocjancic Curty, L., & Pechère, J. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.2281594.x · Cited by 549
Poole, K., Gotoh, N., Tsujimoto, H., Zhao, Q., Wada, A., Yamasaki, T., Neshat, S., Yamagishi, J., Li, X., & Nishino, T. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.281397.x · Cited by 443
Aires, J. R., Köhler, T., Nikaido, H., & Plésiat, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2624 · Cited by 391
Bypassing the periplasm: Reconstitution of the AcrAB multidrug efflux pump of Escherichia coli
Zgurskaya, H. I., & Nikaido, H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7190 · Cited by 360
Clancy, J., Petitpas, J., Dib‐Hajj, F., Yuan, W., Cronan, M., Kamath, A. V., Bergeron, J., & Retsema, J. A. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.01521.x · Cited by 358
Antibiotic Resistance Caused by Gram‐Negative Multidrug Efflux Pumps
Nikaido, H. (1998) · Clinical Infectious Diseases · doi:10.1086/514920 · Cited by 348
Dinh, T., Paulsen, I. T., & Saier, M. H. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.13.3825-3831.1994 · Cited by 325
Multidrug resistance pumps in bacteria: variations on a theme
Lewis, K. (1994) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(94)90204-6 · Cited by 306
Multiple antibiotic resistance and efflux
Nikaido, H. (1998) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(98)80083-0 · Cited by 301
mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae
Tait-Kamradt, A., Clancy, J., Cronan, M., Dib-Hajj, F., Wondrack, L., Yuan, W., & Sutcliffe, J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2251 · Cited by 298
Compounds which increase the permeability of the Pseudomonas aeruginosa outer membrane
Hancock, R. E., & Wong, P. G. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.26.1.48 · Cited by 282
Li, X. Z., Ma, D., Livermore, D. M., & Nikaido, H. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.8.1742 · Cited by 278
Lee, A., Mao, W., Warren, M. S., Mistry, A., Hoshino, K., Okumura, R., Ishida, H., & Lomovskaya, O. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.11.3142-3150.2000 · Cited by 263
Self-citationRenau, T. E., Léger, R., Flamme, E. M., Sangalang, J., She, M. W., Yen, R., Gannon, C. L., Griffith, D., Chamberland, S., Lomovskaya, O., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9904598 · Cited by 260
Self-citationWestbrock-Wadman, S., Sherman, D. R., Hickey, M. J., Coulter, S. N., Zhu, Y. Q., Warrener, P., Nguyen, L. Y., Shawar, R. M., Folger, K. R., & Stover, C. K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2975 · Cited by 242
Kinetics of the multidrug transporter (P-glycoprotein) and its reversal
Stein, W. D. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.2.545 · Cited by 239
Lomovskaya, O., Lee, A., Hoshino, K., Ishida, H., Mistry, A., Warren, M. S., Boyer, E., Chamberland, S., & Lee, V. J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1340 · Cited by 220
Self-citationMultiple Novel Inhibitors of the NorA Multidrug Transporter of Staphylococcus aureus
Markham, P. N., Westhaus, E., Klyachko, K., Johnson, M. E., & Neyfakh, A. A. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.10.2404 · Cited by 218
Oethinger, M., Kern, W. V., Jellen-Ritter, A. S., McMurry, L. M., & Levy, S. B. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.10-13.2000 · Cited by 213
AcrA is a highly asymmetric protein capable of spanning the periplasm 1 1Edited by I. B. Holland
Zgurskaya, H. I., & Nikaido, H. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2313 · Cited by 210
Li, X.-Z., Zhang, L., & Poole, K. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.4.433 · Cited by 176
Role of outer membrane barrier in efflux-mediated tetracycline resistance of Escherichia coli
Thanassi, D. G., Suh, G. S. B., & Nikaido, H. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.4.998-1007.1995 · Cited by 158
Saier, M. H. (1998) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/s0065-2911(08)60130-7 · Cited by 146
The acrAB homolog of Haemophilus influenzae codes for a functional multidrug efflux pump
Sánchez, L., Pan, W., Viñas, M., & Nikaido, H. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.21.6855-6857.1997 · Cited by 142
Uǧurbil, K., Rottenberg, H., Glynn, P., & Shulman, R. G. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.5.2244 · Cited by 127
Chen, H. Y., Yuan, M., & Livermore, D. M. (1995) · Journal of Medical Microbiology · doi:10.1099/00222615-43-4-300 · Cited by 122
Masuda, N., Gotoh, N., Ishii, C., Sakagawa, E., Ohya, S., & Nishino, T. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.400 · Cited by 114
Markham, P. N., & Neyfakh, A. A. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2673 · Cited by 111
Bioenergetics of the Staphylococcal Multidrug Export Protein QacA
Mitchell, B. A., Paulsen, I. T., Brown, M. H., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.6.3541 · Cited by 109
Gotoh, N., Tsujimoto, H., Tsuda, M., Okamoto, K., Nomura, A., Wada, T., Nakahashi, M., & Nishino, T. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.1938 · Cited by 107
Markham, P. N. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.988 · Cited by 97
Nelson, M. L., & Levy, S. B. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1719 · Cited by 96
The Secondary Multidrug Transporter LmrP Contains Multiple Drug Interaction Sites
Putman, M., Koole, L. A., van Veen, H. W., & Konings, W. N. (1999) · Biochemistry · doi:10.1021/bi991262k · Cited by 94
Hooper, D. C. (1995) · Drugs · doi:10.2165/00003495-199500492-00004 · Cited by 93
Nakae, T., Nakajima, A., Ono, T., Saito, K., & Hiroshi Yoneyama, C. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1301 · Cited by 88
nfxC-type quinolone resistance in a clinical isolate of Pseudomonas aeruginosa
Fukuda, H., Hosaka, M., Iyobe, S., Gotoh, N., Nishino, T., & Hirai, K. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.790 · Cited by 86
The Role ofmex-Gene Products in Antibiotic Extrusion inPseudomonas aeruginosa
Hiroshi Yoneyama, C., Ocaktan, A., Tsuda, M., & Nakae, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6506 · Cited by 74
Nelson, M. L., Park, B. H., Andrews, J. S., Georgian, V. A., Thomas, R. C., & Levy, S. B. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00055a008 · Cited by 71
Germ, M., Yoshihara, E., Hiroshi Yoneyama, C., & Nakae, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1045 · Cited by 52
Yoshida, T., Muratani, T., Iyobe, S., & Mitsuhashi, S. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.7.1466 · Cited by 46
Use of steroids to monitor alterations in the outer membrane of Pseudomonas aeruginosa
Plésiat, P., Aires, J., Godard, C., & Köhler, T. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.22.7004-7010.1997 · Cited by 40
Efflux pumps in bacteria: overview, clinical relevance, and potential pharmaceutical target
Lawrence, L. E., & Barrett, J. F. (1998) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.7.2.199 · Cited by 19
Cited by
Multidrug Resistance in Bacteria
Nikaido, H. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082907.145923 · Cited by 1,682
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?
Livermore, D. M. (2002) · Clinical Infectious Diseases · doi:10.1086/338782 · Cited by 1,453
Platforms for antibiotic discovery
Lewis, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3975 · Cited by 1,445
Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria
Piddock, L. J. V. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.382-402.2006 · Cited by 1,231
Metadata
- Authors
- Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., Leger, R., Hecker, S., Watkins, W., Hoshino, K., Ishida, H., & Lee, V. J.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2001-01
- Volume
- 45
- Issue
- 1
- Pages
- 105-116
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2112903691
- Cited by
- 903
- References
- 50
- FWCI
- 14.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.